Neonatal outcomes following early fetal growth restriction: a subgroup analysis of the EVERREST study
Neonatal outcomes following early fetal growth restriction: a subgroup analysis of the EVERREST study
复制标题
DOI：
10.1136/archdischild-2022-325285
复制
发表时间：
2023-04-26
影响因子：
4.4
通讯作者：
David, Anna
中科院分区：
文献类型：
--
作者：
Lingam, Ingran;Okell, Jade;David, Anna
目的探讨极端早产胎儿生长受限（EP-FGR）的死亡率、发病率及出生后特征。设计：EVERREST（血管内皮生长因子基因治疗是否安全地改善严重早发型胎儿生长受限的结局？）对诊断为EP-FGR的女性进行的前瞻性多中心研究（单胎，估计胎儿体重（EFW））
Objective To quantify the risks of mortality, morbidity and postnatal characteristics associated with extreme preterm fetal growth restriction (EP-FGR). Design The EVERREST (Does vascular endothelial growth factor gene therapy safely improve outcome in severe early-onset fetal growth restriction?) prospective multicentre study of women diagnosed with EP-FGR (singleton, estimated fetal weight (EFW)